- nov. 22 - 24 2019
EHA-SWG Scientific Meeting on Systemic Risk of Thrombosis or Bleeding
EHA & the EHA Scientific Working Group on Bleeding and Thrombosis and the EHA Scientific Working Group on Thrombocytopenia and platelet function disorders
Registration for this meeting is now open Register here
The EHA-SWG Scientific Meeting on Systemic Risk of Thrombosis or Bleeding is a three-day meeting dedicated to physicians who take care of patients with thrombotic or hemorrhagic risk. This meeting will teach participants how to recognize these patients, update them on treatments available for reducing these risks, and demonstrate how to weigh the benefits and risk of anti-hemorrhagic and anti-thrombotic therapies.
Below you can find key information and links to important details regarding registration and accommodation. There is also a wide array of sponsorship opportunities available for pharmaceutical companies.
Hematologists, cardiologists, neurologists, pediatricians, internists, patient advocates and clinicians/researchers interested in pathogenesis, diagnosis and treatment of thrombo-hemorrhagic disorders.
The scientific program covers basic science, pathogenesis, diagnosis and treatment of thrombosis and bleeding disorders, including gender-related hemostatic issues and thrombocytopenias. The participants are encouraged to be part of the program both through sessions specifically dedicated to their presentation of clinical cases and results of their research, and by interacting with the invited speakers during sessions and breaks.
This meeting will cover the following topics:
- Venous thromboembolism
- Biological markers to assess the thrombotic risk
- Scoring for bleeding risk
- Platelet threshold for anticoagulant treatments
- Management of bleeding risk in patients with platelet defects
- Bleeding risk of anticoagulation
- Gender-related hemostatic disorders
- Anticoagulant therapy
The full program can be found here.